Trade Sino Biopharmaceutical Limited - 1177 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.04 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.022078% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00016% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 100 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.28 |
| Open | 3.3 |
| 1-Year Change | 9.27% |
| Day's Range | 3.22 - 3.3 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 3.30 | -0.02 | -0.60% | 3.32 | 3.34 | 3.20 |
| Feb 20, 2025 | 3.28 | 0.00 | 0.00% | 3.28 | 3.40 | 3.26 |
| Feb 19, 2025 | 3.30 | 0.00 | 0.00% | 3.30 | 3.36 | 3.28 |
| Feb 18, 2025 | 3.32 | 0.02 | 0.61% | 3.30 | 3.32 | 3.22 |
| Feb 17, 2025 | 3.30 | 0.12 | 3.77% | 3.18 | 3.34 | 3.14 |
| Feb 14, 2025 | 3.20 | 0.10 | 3.23% | 3.10 | 3.22 | 3.08 |
| Feb 13, 2025 | 3.06 | 0.06 | 2.00% | 3.00 | 3.16 | 2.98 |
| Feb 12, 2025 | 3.02 | 0.08 | 2.72% | 2.94 | 3.04 | 2.92 |
| Feb 11, 2025 | 2.92 | -0.08 | -2.67% | 3.00 | 3.00 | 2.92 |
| Feb 10, 2025 | 3.00 | 0.06 | 2.04% | 2.94 | 3.00 | 2.94 |
| Feb 7, 2025 | 2.94 | 0.00 | 0.00% | 2.94 | 2.98 | 2.92 |
| Feb 6, 2025 | 2.94 | 0.08 | 2.80% | 2.86 | 2.94 | 2.84 |
| Feb 5, 2025 | 2.86 | -0.04 | -1.38% | 2.90 | 2.92 | 2.84 |
| Feb 4, 2025 | 2.94 | 0.06 | 2.08% | 2.88 | 2.96 | 2.86 |
| Feb 3, 2025 | 2.82 | 0.18 | 6.82% | 2.64 | 2.84 | 2.64 |
| Jan 28, 2025 | 2.80 | -0.08 | -2.78% | 2.88 | 2.88 | 2.80 |
| Jan 27, 2025 | 2.90 | 0.06 | 2.11% | 2.84 | 2.94 | 2.84 |
| Jan 24, 2025 | 2.84 | 0.00 | 0.00% | 2.84 | 2.94 | 2.80 |
| Jan 23, 2025 | 2.84 | -0.06 | -2.07% | 2.90 | 2.90 | 2.84 |
| Jan 22, 2025 | 2.88 | 0.00 | 0.00% | 2.88 | 2.90 | 2.86 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Sino Biopharmeceutical Company profile
Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. The company's principal products also include Analgesic medicines, such as Kaifen injections and Zepusi Flurbiprofen Cataplasms; Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections and Tianjie tablets; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Aisuping injections and Getai tablets. In addition, it develops medicines for liver, tumor, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; engages in the retail and distribution of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development, medical technology development, and outpatient and surgical procedure services. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.| Industry: | Pharmaceuticals (NEC) |
湾仔港湾道1号会展广场辨公大楼41楼09室
HK
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com